Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One Signs Clinical Interpretation Service Deal with Macrogen

NEW YORK (GenomeWeb) – N-of-One announced today that it has signed a deal to provide Macrogen with clinical interpretation services for its clinical next-generation sequencing-based cancer panels.

"The partnership between Macrogen and N-of-One will further strengthen Macrogen's growth in the clinical setting to enable accessibility of personalized medicine," Macrogen CEO Sang Tae Park said in a statement. "It will deliver comprehensive and clear reports including therapeutic options suited to each patient with information of molecular/clinical relevance and eligible clinical trials for the rapidly growing number of clinical cancer NGS test results."

Specific terms of the arrangement were not disclosed.

The deal marks the latest in a series for N-of-One. Last year, the company inked agreements to provide interpretation services to WuXi, Spectrum Health, GenomiCare, CompanionDx, and Affymetrix.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.